GEORGIA HOSPITAL HEALTH SERVICE & CLASS ACTION CAPITAL PARTNERSHIP PORTAL
Georgia Hospital Health Services (GHHS), a wholly owned subsidiary of the Georgia Hospital Association, has partnered with Class Action Capital, a market leader in class action settlement claim management.
Class Action Capital is already successfully working with a very large number of hospitals, healthcare facilities, and state hospital associations across the country helping to recover meaningful refunds on their behalf from a number of recent class action settlements.
Many healthcare companies do not have the time, resources or relevant data available in order to file a settlement claim. Class Action Capital will work with you in order to submit a fully comprehensive claim recovery, while minimizing the use of your time, internal resources and the risk of mistake if you were to take on claims management on your own.
Settlement Opportunities
Blue Cross Blue Shield Providers Class Action
Plaintiffs allege that Settling Defendants violated antitrust laws by illegally dividing the United States into “Service Areas” and agreeing not to compete in those areas. They also claim that the Settling Defendants fixed prices for services provided. The Court has not decided who is right or wrong, instead, Plaintiffs and Settling Defendants agreed to a $2.8 billion settlement to avoid the risk and cost of further litigation.
Those eligible include all Providers in the United States who currently provide or provided healthcare services, equipment or supplies to any patient who was insured by or was a member of or a beneficiary of any plan administered by any Settling Individual Blue Plan during the class period.
- Settlement Fund: $2.8 billion
- Class Period: July 24, 2008 – October 4, 2024
- Filing Deadline: July 29, 2025
Generic Pharmaceuticals Indirect Reseller and End Payer Classes
Plaintiffs allege that Defendants engaged in unlawful schemes to fix or maintain prices and rig bids that led to inflated prices and reduced competition for various generic medications.
The Indirect Reseller class is comprised of intermediary buyers like hospitals and pharmacies that buy and sell drugs as part of their business model. The End-Payer class is made up of insurance companies and self-insured entities that cover the cost of employee drug purchases. There are 58 defendants and over 200 named generic drugs.
- End-Payer Class
- Settlement Fund: $333,000,000 (projected to be in the billions)
- Class Period: May 1, 2009 – December 31, 2019
- Filing Deadline: TBD
- Indirect Reseller Class
- Settlement Fund: $6.5 million (projected to be in the hundreds of millions)
- Class Period: January 1, 2010 – Present
- Filing Deadline: TBD
Hospital Beds Antitrust Class Action
This complaint alleges that Hill-Rom is purposefully foreclosing the distribution channel by which suppliers sell hospital beds and other medical equipment to healthcare providers through a series of exclusionary tactics. Specifically, over the past decade and continuing today, Hill-Rom has used its market power to impose long-term, exclusive “Corporate Enterprise Agreements” and analogous exclusionary contracts (“CEAs”) on hospital systems throughout the U.S. that prevent them and their constituent hospitals from contracting with other hospital bed suppliers. By unlawfully exploiting its monopoly power to exclude competition, Hill-Rom has foreclosed would-be rivals from being able to discipline Hill-Rom’s monopoly power and pricing, and thereby Hill-Rom has been able to charge, and has charged, supra competitive prices to Plaintiff and similarly situated hospitals for hospital beds.
- Settlement Fund: TBD
- Filing Deadline: TBD
- Class Period: June 20, 2020 – Present
Third Party Payer Opioid Settlement (End Payer Class of Opioid Litigation)
Plaintiffs claim that Defendants played a central role in the opioid crisis. They claim that to sell as many prescription opioids as possible, manufacturers misrepresented the risks and safety of long-term prescription opioid use and distributors did not properly monitor or report suspicious orders. Plaintiffs claim that Defendants’ conduct caused substantial, direct, and proximate harm to Third-Party Payor Plaintiffs. Because of the opioid crisis, TPPs claim they have wrongfully had to pay large costs for opioid prescriptions and opioid use disorder treatment.
All entities that paid and/or were reimbursed for: (i) opioid prescription drugs manufactured, marketed, sold, distributed, or dispensed by any of the Defendants and/or Opioid Supply Chain Members for purposes other than resale; and/or (ii) paid or incurred costs for treatment related to the misuse, addiction, and/or overdose of opioid drugs, on behalf of individual beneficiaries, insureds, and/or members, during the time period from January 1, 1996 to the date of entry of the Preliminary Approval Order.
- Settlement Fund: $300,000,000
- Class Period: January 1, 1996 – Present
- Filing Deadline: Jun 20, 2025
MultiPlan Insurance Provider Litigation
According to the complaint, Multiplan, Inc. is a company that helps health insurers underpay struggling healthcare providers. They started as a company that sold nationwide “wrap” networks of contracted providers to insurance companies so that insurers could supplement their own networks available to members of their PPO insurance plans. Over the past decade, it is alleged that MultiPlan has morphed into a company that offers what it calls “claims repricing” services to address the bills insurers receive when a member receives care not covered by those insurers preferred network. It is alleged that MultiPlan suppresses and fixes the prices insurers pay physicians for “out-of-network” medical care. Any time the word “repricing” is used to describe MultiPlan’s services it should be understood to mean “price fixing.”
All persons or entities who received reimbursement for out-of-network medical care from one or more of the Defendants or Co-Conspirators from than July 1, 2017, until the anticompetitive effects of the alleged unlawful misconduct cease.
- Settlement Fund: TBD
- Filing Deadline: TBD
- Class Period: July 1, 2017 – Present